Stock Track | Moderna Plummets 5.01% Intraday as Investors Question 2028 Cash Breakeven Target

Stock Track01-13

Moderna, Inc. (MRNA) saw its shares plummet 5.01% during Monday's intraday trading session, underperforming the broader healthcare sector.

The decline came despite the company reiterating its 2025 revenue forecast of approximately $1.9 billion and improving its operating expense guidance. Analysts at Jefferies expressed skepticism about Moderna's ability to achieve cash breakeven by 2028, stating that "more reductions are needed to instill investor confidence." This skepticism overshadowed the company's positive updates, including potential vaccine approvals in 2026.

The healthcare sector broadly declined during the session, with the NYSE Health Care Index down 0.5% and the iShares Biotechnology ETF (IBB) falling 1.8%, contributing to the negative sentiment around Moderna's stock.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1110907677?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-13 02:58","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1110907677","market":"hk","top_or_hot":-1,"title":"Stock Track | Moderna Plummets 5.01% Intraday as Investors Question 2028 Cash Breakeven Target","media":"Stock Track","content":"<p>Moderna, Inc. (MRNA) saw its shares plummet 5.01% during Monday's intraday trading session, underperforming the broader healthcare sector.</p><p>The decline came despite the company reiterating its 2025 revenue forecast of approximately $1.9 billion and improving its operating expense guidance. Analysts at Jefferies expressed skepticism about Moderna's ability to achieve cash breakeven by 2028, stating that \"more reductions are needed to instill investor confidence.\" This skepticism overshadowed the company's positive updates, including potential vaccine approvals in 2026.</p><p>The healthcare sector broadly declined during the session, with the NYSE Health Care Index down 0.5% and the iShares Biotechnology ETF (IBB) falling 1.8%, contributing to the negative sentiment around Moderna's stock.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Moderna Plummets 5.01% Intraday as Investors Question 2028 Cash Breakeven Target</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Moderna Plummets 5.01% Intraday as Investors Question 2028 Cash Breakeven Target\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-01-13 02:58</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Moderna, Inc. (MRNA) saw its shares plummet 5.01% during Monday's intraday trading session, underperforming the broader healthcare sector.</p><p>The decline came despite the company reiterating its 2025 revenue forecast of approximately $1.9 billion and improving its operating expense guidance. Analysts at Jefferies expressed skepticism about Moderna's ability to achieve cash breakeven by 2028, stating that \"more reductions are needed to instill investor confidence.\" This skepticism overshadowed the company's positive updates, including potential vaccine approvals in 2026.</p><p>The healthcare sector broadly declined during the session, with the NYSE Health Care Index down 0.5% and the iShares Biotechnology ETF (IBB) falling 1.8%, contributing to the negative sentiment around Moderna's stock.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MRNA","symbol_name":"Moderna, Inc.","start_time":0,"source_url":"","article_id":"1110907677","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1110907677","pubTimestamp":1768244307,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Moderna, Inc. (MRNA) saw its shares plummet 5.01% during Monday's intraday trading session, underperforming the broader healthcare sector.The decline came despite the company reiterating its 2025...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"MRNA":"Moderna, Inc."},"translate_title":"个股追踪|Moderna盘中暴跌5.01%投资者质疑2028年现金盈亏平衡目标","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MRNA":1},"content_text":"Moderna, Inc. (MRNA) saw its shares plummet 5.01% during Monday's intraday trading session, underperforming the broader healthcare sector.The decline came despite the company reiterating its 2025 revenue forecast of approximately $1.9 billion and improving its operating expense guidance. Analysts at Jefferies expressed skepticism about Moderna's ability to achieve cash breakeven by 2028, stating that \"more reductions are needed to instill investor confidence.\" This skepticism overshadowed the company's positive updates, including potential vaccine approvals in 2026.The healthcare sector broadly declined during the session, with the NYSE Health Care Index down 0.5% and the iShares Biotechnology ETF (IBB) falling 1.8%, contributing to the negative sentiment around Moderna's stock.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1110907677","isCrawlerRequest":true}